According to the World Health Organization, there are 48 vaccine candidates in clinical trials and 164, still in the pre-clinical testing phase. Let’s analyze efficacy, safety and timing of the three the protagonists of this race.
Today we remember and support #WorldAIDSDay. Medical research has seen amazing advances and milestones over the past few decades. Here at IRBM, we are proud to have played a major role in the discovery of Raltegravir (Isentress) while part of Merck & Co, for the treatment of #HIV-1 infection in combination with other antiretroviral agents.
In addition, our ADVENT GMP facility has manufactured clinical lots of an HIV adenovirus-based vaccine for the Jenner Institute, Oxford which we hope will progress to an approved therapy for the prevention of #AIDS.
The Jenner Institute release: https://www.jenner.ac.uk/about/news/phase-i-hiv-vaccine-trial-completes-volunteer-recruitment-in-time-for-world-aids-day
EAVI2020 consortium release: https://www.eavi2020.org/eavi2020-continues-the-fight-world-aids-day-2021/